Medications ›norfloxacin

norfloxacin

RxCUI 7517 ingredient

Contraindicated with · 8

Diagnoses2

Condition families6

Tendon Injuries Muscular Diseases Wounds and Injuries Musculoskeletal Diseases Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 34

Diagnoses8

Prostatitis Cystitis Conjunctivitis, Bacterial Gonorrhea Eye Infections, Bacterial Conjunctivitis Sexually Transmitted Diseases, Bacterial Genital Diseases, Male

Condition families26

Pseudomonas Infections Neisseriaceae Infections Urinary Bladder Diseases Conjunctival Diseases Haemophilus Infections Eye Infections Pasteurellaceae Infections Prostatic Diseases Escherichia coli Infections Urinary Tract Infections Enterobacteriaceae Infections Sexually Transmitted Diseases Staphylococcal Infections Communicable Diseases Gram-Negative Bacterial Infections Gram-Positive Bacterial Infections Genital Diseases Eye Diseases Bacterial Infections Bacterial Infections and Mycoses Urologic Diseases Male Urogenital Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases Infections

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.